Clinical Trials Browser

Phase 3 × Venous Thrombosis × Rivaroxaban × Clear all

NCT04309240 2020-03-16

Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports

Phase 3 Unknown

Neoplasms, Venous Thrombosis